Futamura, Manabu http://orcid.org/0000-0001-5622-8352
Ishihara, Kazuhiro
Nagao, Yasuko
Ogiso, Atsuko http://orcid.org/0000-0001-6284-4899
Niwa, Yoshimi
Nakada, Takumi
Kawaguchi, Yoshihiro
Ikawa, Ai
Kumazawa, Iwao
Mori, Ryutaro
Kitazawa, Mai
Hosono, Yoshiki
Kuno, Masashi
Kawajiri, Mana
Nakakami, Akira
Takeuchi, Makoto
Morikawa, Akemi
Tokumaru, Yoshihisa http://orcid.org/0000-0003-2481-7739
Katagiri, Yasuo
Asano, Yoshimasa
Mushika, Yoshinori
Shimokawa, Toshio
Matsuhasih, Nobuhisa
Article History
Received: 19 August 2022
Accepted: 9 December 2022
First Online: 7 January 2023
Declarations
:
: MF-Remuneration: Chugai, Taiho, Takeda, Kaken-Seiyaku, Nippon-Kayaku, Daiichi-Sankyo, AstraZeneca, Pfizer, Lilly, and Eisai. KI-Remuneration: Nihon-Kayaku, Kyowa-Hakko-Kirin, Daiichi-Sankyo, and Eisai. YN-Remuneration: Kyowa-Hakko-Kirin. TN-Remuneration: Daichi-Sankyo, Pfizer, Chugai, Taiho, AstraZeneca, and Lilly. YK-Remuneration: Chugai, Daiichi-Sankyo, Kyowa-Hakko-Kirin, Taiho, and Eisai. AM-Remuneration: Chugai and Eisai.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.